Serial Number
97461217
Owner
CRISPR Therapeutics AGAttorney
Tiffany D. GehrkeFirst Use Date
Nov 17, 2023
Filing Date
Jun 16, 2022
CTX310 Trademark
Serial Number: 97461217 • Registration: 8005333
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Tiffany D. Gehrke MARSHALL, GERSTEIN & BORUN LLP
233 SOUTH WACKER DRIVE
6300 WILLIS TOWER
CHICAGO, IL 60606
United States
Trademark Details
Filing Date
June 16, 2022
Registration Date
October 28, 2025
First Use Anywhere
November 17, 2023
First Use in Commerce
November 17, 2023
Published for Opposition
April 23, 2024
Goods & Services
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy
Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of cardiovascular diseases; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease in the field of in vivo gene editing therapy